GEDEA BIOTECH
Gedea Biotech develops an antibiotic-free, safe and effective treatment of vaginal fungal infections. Vaginal yeast infections are a major problem that affects about 75% of all women at some point in life. Gedea Biotech's substance, GA101, is a natural substance that has always been part of their environment. It acts by lowering the pH as well as providing a physical barrier protection and inhibiting biofilm formation. The first product will be a topical treatment of vaginal fungal infections.
GEDEA BIOTECH
Social Links:
Industry:
Biotechnology Health Care
Founded:
2015-01-01
Address:
Lund, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.gedeabiotech.com
Total Employee:
1+
Status:
Active
Total Funding:
1.39 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Content Delivery Network Font Awesome Microsoft Exchange Online
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
CeQur
CeQur develops and commercializes insulin delivery systems, giving people with type 2 diabetes freedom from multiple daily injections.
EnBiotix
EnBiotix advances front-line labeled products for chronic, recurrent, and life-threatening pulmonary infections.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Investors List
Additio Investment Group
Additio Investment Group investment in Series A - Gedea Biotech
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Gedea Biotech
Porte Monnaie
Porte Monnaie investment in Venture Round - Gedea Biotech
Almi Invest
Almi Invest investment in Venture Round - Gedea Biotech
SmiLe Incubator
SmiLe Incubator investment in Seed Round - Gedea Biotech
Official Site Inspections
http://www.gedeabiotech.com Semrush global rank: 10.37 M Semrush visits lastest month: 1
- Host name: marisha.oderland.com
- IP address: 46.16.236.20
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
More informations about "Gedea Biotech"
Gedea Biotech - Gedea Biotech
According to the World Health Organization (WHO), antibiotic resistance is a growing problem and one of the biggest threats to global public health. Our business concept is to develop a โฆSee details»
Gedea Biotech - Crunchbase Company Profile & Funding
Gedea Biotech may be growing due to the prestigious grant funding it has been selected for from the European Innovation Council. This financial support is โฆSee details»
Gedea Biotech AB Overview | SignalHire Company Profile
Organization Website: gedeabiotech.com : Phone Number: 46-0-708-91-86-81: Gedea Biotech AB industries Biotech: Headquarters Location: Medicon Village, Lund, Skane, 22381 SE โฆSee details»
Sustainability - Gedea Biotech
Equality and sustainability are our most important guiding principles and influence all areas of our work. According to the World Health Organization (WHO), antibiotic resistance is a growing problem and one of the biggest threats to โฆSee details»
Gedea Biotech AB - LinkedIn
Gedea Biotech develops pHyph to treat and prevent recurrence of bacterial vaginosis. Bacterial vaginosis (BV) is a very common condition with a prevalence of 10-30% for women of โฆSee details»
Gedea Biotech AB - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Gedea Biotech AB of Lund, Skåne. Get the latest business insights from Dun & Bradstreet.See details»
Gedea Biotech Company Profile 2025: Valuation, Funding
Gedea Biotech General Information Description. Developer of an antibiotic-free treatment intended to treat and prevent vaginal bacterial and fungal infections. The company's treatment โฆSee details»
Gedea Biotech AB - Company Profile and News - Bloomberg โฆ
Company profile page for Gedea Biotech AB including stock price, company news, executives, board members, and contact informationSee details»
Gedea Biotech - Company Profile - Tracxn
Dec 6, 2024 Gedea Biotech - Provider of therapeutics for treating vaginal microbial infections. Raised a total funding of $1.63M over 7 rounds from 9 investors. Founded by Helena Strevens โฆSee details»
Gedea Biotech - Craft
Gedea Biotech is a company developing an antibiotic-free treatment of vaginal fungal infections. It offers pHyph, a vaginal tablet expected to cure bacterial vaginosis and prevent the infection โฆSee details»
Gedea Biotech Company Profile: Overview and Full News Analysis
Gedeabiotech.com. Overview: Gedea Biotech. Gedea Biotech, located in Skane Lan, is a company focused on developing innovative solutions for women's health issues. Their flagship โฆSee details»
Gedea Biotech AB (Gedea Biotech AB) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ โฆ
The combined organization will focus on translating growth factor signaling pathways into innovative therapies. Agomabโs hepatocyte growth factor (HGF)-targeting monoclonal โฆSee details»
Gedea Biotech Company Information - Funding, Investors, and More
Get information on funding, investors, industries, and more for Gedea Biotech. See Gedea Biotech company profile and funding data.See details»
Gedea Biotech AB - edgein.io
Gedea Biotech developes pHyph to treat and prevent recurrence of bacterial vaginosis. Bacterial vaginosis (BV) is a very common condition with a prevalence of 10-30% for women of โฆSee details»
Gedea Biotech - Products, Competitors, Financials, Employees ...
Gedea´s share issue oversubscribed by 54%. Nov 6, 2024. Gedea Biotech AB Wed, Nov 06, 2024 11:00 CET Gedea Biotech AB carried out a rights issue of SEK 24.3 million during October.See details»
A great milestone reached in the Gedea Biotech - LINK Medical
UPPSALA, Sweden, February 2, 2021 โ LINK Medical, the Northern European clinical research organization (CRO), and the Swedish womenโs health company Gedea Biotech announced โฆSee details»
News - Gedea Biotech
Dec 3, 2024 PRESS RELEASE. Yesterday, the EIC announced that Gedea Biotech has been selected for the โฌ2.5M EIC Accelerator grant for the continued development and โฆSee details»
Swiss-based Non-profit GARDP Supports the Development
4 days ago We are a not-for-profit global health organization driven to protect people from the rise and spread of drug-resistant infections, one of the biggest threats to us all. By forging the โฆSee details»
News - Gedea Biotech
May 24, 2018 On Thursday November 28th, at the Nordic Mentor Network For Entrepreneurship - NOME annual meeting in Copenhagen, we were honored to receive the Arvind Hundal Scale โฆSee details»
Two mentions and one article in three publications during end of ...
Dec 5, 2022 News . The results from the NEFERTITI-study have received much attention since they were first published in a press release from October 11th. During the last week of โฆSee details»